Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of dexamethasone palmitate injection for knee osteoarthritis
CTR20244949Phase 3Completed
- Sponsor
- Guangzhou Green Cross Pharmaceutical
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in knee osteoarthritis (OA), sponsored by Guangzhou Green Cross Pharmaceutical. Started Jan 2025; status: completed.
02
Drugs
dexamethasone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20244949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244949.